Gladstone Capital Management’s Intercontinental Exchange ICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Buy
8,300
+8,200
+8,200% +$1.34M 0.13% 17
2025
Q4
$16.2K Sell
100
-157,789
-100% -$24.7M ﹤0.01% 26
2025
Q3
$26.6M Sell
157,889
-455,965
-74% -$81.5M 2.91% 11
2025
Q2
$113M Buy
613,854
+29,518
+5% +$5.07M 11.62% 2
2025
Q1
$101M Buy
584,336
+294,220
+101% +$48.2M 10.38% 4
2024
Q4
$43.2M Buy
+290,116
New +$46M 3.6% 13
2022
Q2
Sell
-1,590,769
Closed -$210M 15
2022
Q1
$210M Buy
1,590,769
+24,134
+2% +$3.12M 10.82% 5
2021
Q4
$214M Buy
1,566,635
+653,518
+72% +$86.6M 9.59% 4
2021
Q3
$105M Buy
913,117
+476,617
+109% +$56.6M 5.28% 10
2021
Q2
$51.8M Buy
+436,500
New +$50.2M 2.82% 11

Other funds holding ICE

Gladstone Capital Management's ICE Position: Q1 2026 in Review

Gladstone Capital Management increased its Intercontinental Exchange (ICE) stake by 8,200% in Q1 2026, buying an estimated $1.34M and bringing the position to 8,300 shares worth $1.31M. The position accounts for 0.13% of the portfolio, ranked #17.

Gladstone Capital Management first reported a position in ICE in Q2 2021 and has held it in 10 quarters since. The position peaked at $214M in Q4 2021. 1,721 funds tracked by Wall St. Rank hold ICE as of Q1 2026.

  • Gladstone Capital Management held 8,300 shares of Intercontinental Exchange worth $1.31M as of Q1 2026.
  • Gladstone Capital Management bought 8,200 Intercontinental Exchange shares in Q1 2026, an estimated $1.34M.
  • Intercontinental Exchange made up 0.13% of Gladstone Capital Management's portfolio in Q1 2026, its #17 holding.
  • Gladstone Capital Management first reported a position in Intercontinental Exchange in Q2 2021 and has held it in 10 quarters since.
  • Gladstone Capital Management's Intercontinental Exchange position peaked at $214M in Q4 2021.
  • 1,721 funds tracked by Wall St. Rank held Intercontinental Exchange as of Q1 2026.

Based on Gladstone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.